Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Thanks Dalts, Are you able to share this as a link please. Can’t...

First 26 Last

Share
Profile

Follow
dsorg

864 Posts.

590

22/12/20

18:55

Post #: 49763501
Share
Originally posted by dalts66 ↑

Some very good reasoning here.

THC has gained a pretty bad reputation, however, when used/dosed correctly it has huge medical benefits. Lots of authorities and even some investment houses will not allow or deal with products containing THC. This is mostly because there are not many cannabis products on the market containing THC so there hasn't been a lot of data to support its use. In recent years this is finally starting to change, as two companies that I know of (well three if we count IHL), have whole of plant product in there pipelines, and have clinical trial data to support its use and safety. In fact the TGA has just recently approved the sale of two product within Australia for the treatment of children's Autism, and both of these contain THC cannabinoids in different strengths. TGA has also this year approved an Insomnia formulation that also contains THC. This would suggest that the TGA will have no problem approving a OSA drug containing THC is support by trial data.

For those not familiar with how Medical Cannabis works I have stolen an article from "Planted.com" that does a great job of explaining how the human body, THC and CBD all get along.

"The Endocannabinoid System

The endocannabinoid system (ECS) is one of the body’s largest neurotransmitter networks but was only discovered in the 1980’s — two decades after THC. The ECS is always working to achieve balance, or homeostasis, which means maintaining a stable internal environment despite changes in the external environment.
Or, balance for our systems, despite the constant chaos of the outside world.
As you can imagine, this is a crucial physiological system to keep us healthy.
At its most simple, the ECS’s communications are composed of messengers and receptors. The brain naturally produces endocannabinoid molecules (like anandamide and 2-arachidonoylglycerol, or 2-AG), which are home-grown messengers that can be found in your brain, organs, connective tissues, glands, and immune cells.
Explore In-Depth: CBD vs. THC
Endocannabinoids, like anandamide, act like the body’s natural THC but have a much shorter effect in the body than THC does. In fact, anandamide comes from the Sanskrit word for “bliss”, making it the body’s natural “blissful” molecule. There are also plant cannabinoids that are found in cannabis (THC and CBD are the biggest), and synthetic cannabinoids, which are lab-created and can be up to 600 times more powerful than THC.
Cannabinoids look for and activate cannabinoid receptors (CB1 and CB2) and when they get together they tell your body to feel a certain way and do certain things. They also affect and regulate the way other bodily systems function, like your immune, nervous, and gastrointestinal systems.
The best way to describe the ECS is as a balancing system (or homeostatic regulator): it sends neurotransmitters (messenger + communication molecules) to all your bodily parts to check that everything is working smoothly and confirm if anything needs to be rebalanced. When it finds a problem, it regulates it by sending further instructions to receptors that adjust how you feel and think.
So, what does it keep tabs on?

fertility, pregnancy, and reproductive systems

appetite, hunger, and digestive systems

sleep

motor control

pain and pleasure

immune function

effects of other cannabinoids

temperature

mood

memory

The woefully-understudied ECS underpins most of our body’s systems, like the immune, gastrointestinal, central and peripheral nervous, reproductive, digestive, and more. So it represents a crucial opportunity for many researchers to uncover more answers about the medicinal benefits of cannabis. As cannabis moves towards the mainstream, more research to understand receptors and our ECS are sure to come.
The natural “bliss” molecule: anandamide

The body’s best-known endocannabinoid, anandamide, does more than just make you feel “blissful”… it’s synthesized in parts of the brain that are important for:

memory

motivation

higher thought processes

movement, as well as

pain, appetite, and fertility.

When we understand what role anandamide plays in our bodies naturally, we gain a greater understanding of the possibilities of THC.
Anandamide is the chemical that helps us forget unimportant details, improve our happiness and increase neurogenesis (creates new nerve cells). It also rewards us for a job well done (runner’s high) while battling anxiety and depression. Now that’s a versatile, hard-working chemical.
Researchers believe that if you naturally have more anandamide, you have less use for cannabis. But can you imagine if your body wasn’t creating enough?
That’s a lot of crucial functionality for life that can go haywire.
Types of cannabinoid receptors

Don’t get us wrong, cannabis can and does interact with cannabinoid receptors — but the receptors weren’t created for cannabis. They were created as part of the ECS to receive endocannabinoids (and the messages they send) from your brain. Interestingly enough, these receptors also far outnumber any other receptor found in the brain.
Technically, the ECS is just being supplemented when a person consumes cannabis and their receptors are stimulated. Thankfully, this means that many deficiencies and overexpression of certain characteristics of the disease can be “course-corrected” by plant-based cannabinoids like THC and CBD.
As we mentioned, there are 2 main types of receptors: CB1 and CB2.
Cannabinoid Receptor 1 (CB1) receptors are mainly located in the brain and nervous system, as well as in the lungs, liver, and kidneys. Our natural endocannabinoids and the cannabinoid THC from cannabis mainly bind with CB1 (due to their similar molecular structure). This gives patients relief from pain, nausea, and depression, among other things.
Cannabinoid Receptor 2 (CB2) receptors are found mainly in the immune system, with a heavy concentration in the spleen and in the gastrointestinal system. CB2 receptors — which bind best with the endocannabinoid 2-AG and cannabis’ CBD — are involved in the regulation of appetite, immune system functions like inflammation and pain management.
Scientists are on the cusp of determining a third type of cannabinoid receptor (for CBN), but research in this area is ongoing and inconclusive as of now.
How cannabinoid receptors work

The best way to imagine cannabinoids and their receptors is like a lock and key. When a person consumes cannabis, the cannabinoids THC and CBD (keys) flood your body in search of receptors (locks).
When they find one that fits, the effects of the cannabinoid and the function and location of the receptor “click” together and messages are sent through the rest of your body.
As an example: Taking a dose of CBD oil (which will typically bind with the CB2 receptor) can inhibit your appetite, whereas a THC-rich strain can increase appetite because it binds more readily with the CB1 receptor. Hence why you get “munchies” from certain strains of cannabis, but not from others.
However, the ECS is unique in that it communicates “backward”: this particular sort of cell-to-cell communication inhibits the immune response, reduces inflammation, relaxes muscles, lowers blood pressure, and normalizes stimulated nerves. Basically, our natural endocannabinoids “check” to make sure not too much is happening in your body before accepting more stimulation or the system creating more messages.
Explore In-Depth: What is CBD oil?
What this means is that endocannabinoids are created “on demand” and can act as a “dimmer switch” that affect how quickly, often, and where messages get transmitted.
That’s why the ECS is so crucial to proper functioning and health. Dysregulation of the ECS contributes to a wide variety of conditions that prevent the body from achieving balance, like fibromyalgia or IBS. Whether it’s an overproduction of an enzyme, protein, or an overexpression of receptors, if the ECS isn’t functioning correctly your body has a difficult time regulating its emotions, appetite, memory, and everything else the ECS is responsible for.
Though the lock and key analogy does a good job of explaining the basics, the ECS is more nuanced and complex than scientists can confirm even today. While THC works in line with the lock-and-key analogy (binding directly to receptors by mimicking endocannabinoids), CBD works to increase the amount of endocannabinoids in your system by altering the way enzymes work.
How does it do this?
The FAAH enzyme’s job is to remove extra anandamide from your system by breaking it down (thus decreasing happiness and “bliss”. CBD stops FAAH from doing that, thus leaving more endocannabinoids out for consumption by the rest of your body. This way, not only is there more “bliss” hanging around, there’s also the effects of the pain-relieving and non-psychoactive CBD.
Balance of CB1 and CB2 receptors

Beyond affinity for binding with certain molecules, receptors are also located in different body parts and have different density and numbers, which is considered to be the “expression” of the receptors.
The expression of receptors is as unique person-to-person as fingerprints. Everybody has a different balance, number, and concentration of them, which is why experimenting with cannabis medication is such a delicate and slow process. Different expressions of cannabinoid receptors mean different experiences consuming the same type of cannabis.
The increased density of CB2 receptors in the gastrointestinal system is a great example of why patients with Crohn’s or IBS benefit so much from cannabis medication: CBD-rich medication binds with all the receptors in your gastrointestinal tract and provides pain relief and relief from the inflammation typical in those diseases.
Another example is an over-expression (too many) of CB1 receptors causing a patient to be overly sensitive to THC, leading to munchies or other side effects much quicker than others. If patients under-express the CB2 receptor, they would need to consume greater quantities, other cannabinoids, or specific terpenes along with CBD to feel its’ healing effects.
While cannabinoids have flexibility about the receptors they bind with, having a general understanding of the likelihood (or affinity) for bonding with receptors and their locations, functions, and expressions can help patients. Meaning they can have deeper, more meaningful discussions with their physician and come up with stronger treatment plans.
It’s important to keep abreast of studies about cannabis that are constantly being updated with findings of receptors, cannabinoids and how they work.
Cannabinoid receptors in action

Knowing about cannabinoids, terpenes, and the endocannabinoid system can only help you get a better grasp of how cannabis affects your body. Scientists that are exploring the endocannabinoid system have found information regarding the following conditions:
Epilepsy

Patients with epilepsy have recently been recommended a CBD-rich, low-THC strain because of its anti-inflammatory and possible anticonvulsant properties and its’ bonding with CB2 receptors. The side effects for typical anticonvulsant medications are miles long as opposed to the calming, non-psychactive, and healing effects of CBD.
IBS or Crohn’s

Because CB2 receptors are located densely in the gastrointestinal system (as mentioned above), they are responsible for regulating inflammatory responses for the system — which is good news for patients who use CBD for gastrointestinal issues like IBS or Crohn’s.
PTSD

Patients that suffer with PTSD have had increasing success with THC, due to its’ mimicry of our natural endocannabinoid anandamide. While at first its’ ability to help us forget unimportant details (or mental clutter) is strange, using that functionality to help patients overcome negative memories surrounding a traumatic event and increasing their mood has proven to be very successful and helpful.
General Mental Health

Researchers have found that mice without CB1 receptors show “psychological abnormalities” like increased anxiety and enlarged amygdalas (responsible for emotions and motivation). Genetic studies show that CB1 receptors are important for reducing and controlling anxiety during high-stress periods, so having less or none of these receptors can cause complications.
Reminders about Cannabinoid Receptors

Humans come equipped with an Endocannabinoid System (ECS), which include endocannabinoids and cannabinoid receptors, which function like a lock-and-key

The ECS underlies and controls the balance of all your other bodily systems by being a great communicator

We have 2 different types of receptors — CB1 and CB2 — that are responsible and built for accepting and locking with different types of molecules

CB1 is a great fit for anandamide and THC

CB2 is generally receptive and activated by CBD

Endocannabinoids are naturally produced by our bodies, but we can supplement them by learning more about plant cannabinoids, derived from cannabis

When the ECS is dysregulated, your body has difficulty communicating with your brain and vice versa

Scientists are discovering new things about cannabinoids and cannabinoid receptors every year, so it’s important to keep up on the latest studies to update your knowledge and inform your health care plan

Everybody’s ECS is totally different — like a fingerprint — which is why everyone experiences cannabis in different ways, and why it’s crucial to…

Start low, and go slow when experimenting with cannabis.

Expand

Thanks Dalts,

Are you able to share this as a link please. Can’t find it online and it’s one of the better (easier) explanations of the endocannabinoid system. Especially the little bit about anandamide. Such an understated chemical in our body! Cheers
IHL Price at posting: 15.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Essential Energy conference: Streamlining approvals key to the green energy transition

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

There are more pages in this discussion • 15 more messages in this thread...

First 26 Last

Add IHL (ASX) to my watchlist